No Data
Lacklustre Performance Is Driving Repare Therapeutics Inc.'s (NASDAQ:RPTX) 26% Price Drop
Strategic Shift and Uncertainties Lead to Hold Rating for Repare Therapeutics
Stifel Maintains Repare Therapeutics(RPTX.US) With Buy Rating, Cuts Target Price to $3
Repare Therapeutics Price Target Lowered to $3 From $4 at Stifel
LifeSci Capital Maintains Repare Therapeutics(RPTX.US) With Hold Rating
Repare Therapeutics (RPTX) Gets a Hold From LifeSci Capital
止跌回稳 : I purchased it first, hoping the carnival won't take too long to arrive.